Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift


Hereditary deficiencies of protein S (PS) increase the risk of thrombosis. However, assessing the plasma levels of PS is complicated by its manifold physiological interactions, while the large inter-individual variability makes it problematic to establish reliable cut-off values. PS has multiple physiological functions, with only two appearing to have significant anticoagulant properties: the activated protein C (APC) and tissue factor pathway inhibitor alpha (TFPIα) cofactor activities. Current clinical laboratory investigations for deficiency in PS function rely only on the APC-dependent activity. This communication presents an argument for reclassifying the qualitative PS deficiencies to differentiate the two major anticoagulant functions of PS. Reliable assays are necessary for accurate evaluation of PS function when making a specific diagnosis of PS deficiency based on the anticoagulant phenotype alone. This report emphasizes the pleiotropic anticoagulant functions of PS and presents evidence-based recommendations for their implementation in the clinical laboratory.


  • Herm Jan M. Brinkman
  • Josefin Ahnström
  • Elisabetta Castoldi
  • Björn Dahlbäck
  • Richard A. Marlar
Enheter & grupper
Externa organisationer
  • Imperial College London
  • University of New Mexico
  • Sanquin Research
  • Maastricht University
  • TriCore Reference Laboratories, Albuquerque

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Kardiologi
  • Läkemedelskemi


Sidor (från-till)281-286
Antal sidor6
TidskriftJournal of Thrombosis and Haemostasis
Utgåva nummer1
StatusPublished - 2021
Peer review utfördJa